Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jul 27, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness and safety of various Endoscopic Bariatric Therapies (EBTs), which are non-surgical procedures designed to help patients lose weight. The researchers want to gather information from both past and current patients to see how these treatments work over time. If you are at least 18 years old and are either considering an EBT for weight loss or have already had one in the last six months, you may be eligible to participate in this study.
Participants in this trial can expect to have their medical records reviewed and to attend regular visits over the course of a year. This will help the researchers understand how EBTs affect weight loss and related health conditions, like gastroesophageal reflux disease (GERD). The study is open to everyone, regardless of gender, and is currently recruiting participants. It's a great opportunity to contribute to important research that could help improve weight loss treatments for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
- • Above or equal to 18 years of age.
- Exclusion Criteria:
- • Any patient who has not undergone or will undergo EBT for weight loss
- • Below 18 years of age.
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Reem Z Sharaiha, MD
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials